Spectrum Chemical Manufacturing Corporation has entered into an agreement with BASF Corporation to provide precious-metal-containing powder catalysts to pharmaceutical customers in North America. The agreement will enable customers making next-generation product breakthroughs to speed up commercialization and scale-up production.

In today’s marketplace when pharmaceutical researchers discover an innovative ingredient combination they need to scale up quickly. This agreement brings together Spectrum‘s extensive customer network with BASF scale-up-ready catalysts, so the materials can be considered early in the development phase. Spectrum will offer 26 BASF catalysts consisting of precious metals such as palladium, platinum, rhodium and ruthenium, with carriers of carbon, alumina and calcium carbonate.

“We are excited to add these proven catalysts to our industry-leading chemistry portfolio,” said Randy Burg, President and CEO of Spectrum. “Our broad network of customers will receive access to products from the global leader in catalysts, but in the smaller quantities they need for early product development throughout North America.”